Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-024522

Chief Executive Officer gave up 5,219 shares (to pay taxes)

  • Chief Executive Officer acquired 19,768 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quart Barry D Chief Executive Officer 2022-04-13 Option exercise +3,646 120,281 D
Quart Barry D Chief Executive Officer 2022-04-13 Option exercise +16,122 136,403 D
Quart Barry D Chief Executive Officer 2022-04-13 Shares withheld for taxes −5,219 $6.07 $31,679 131,184 D
Derivatives
Quart Barry D Chief Executive Officer 2022-04-13 Option exercise · Restricted Stock Units −3,646 36,458 D
Quart Barry D Chief Executive Officer 2022-04-13 Option exercise · Restricted Stock Units −16,122 163,173 D
Loading xslF345X03/doc4.xml…